Fifth Third Wealth Advisors LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 94.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,338 shares of the medical equipment provider's stock after purchasing an additional 4,050 shares during the period. Fifth Third Wealth Advisors LLC's holdings in Intuitive Surgical were worth $4,096,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of ISRG. Prospera Financial Services Inc raised its position in shares of Intuitive Surgical by 264.6% in the third quarter. Prospera Financial Services Inc now owns 17,238 shares of the medical equipment provider's stock valued at $8,468,000 after purchasing an additional 12,510 shares during the period. OneAscent Financial Services LLC raised its holdings in Intuitive Surgical by 4.8% during the 3rd quarter. OneAscent Financial Services LLC now owns 2,161 shares of the medical equipment provider's stock worth $1,062,000 after purchasing an additional 98 shares during the last quarter. Chesapeake Wealth Management increased its stake in shares of Intuitive Surgical by 2.2% in the 3rd quarter. Chesapeake Wealth Management now owns 2,312 shares of the medical equipment provider's stock valued at $1,136,000 after acquiring an additional 50 shares during the last quarter. Caprock Group LLC increased its stake in Intuitive Surgical by 9.8% during the 3rd quarter. Caprock Group LLC now owns 8,253 shares of the medical equipment provider's stock worth $4,055,000 after purchasing an additional 737 shares in the last quarter. Finally, Pathstone Holdings LLC boosted its position in Intuitive Surgical by 2.6% during the 3rd quarter. Pathstone Holdings LLC now owns 48,928 shares of the medical equipment provider's stock worth $24,037,000 after acquiring an additional 1,228 shares during the last quarter. Institutional investors own 83.64% of the company's stock.
Intuitive Surgical Price Performance
Shares of NASDAQ:ISRG traded up $6.73 on Tuesday, hitting $538.37. The company's stock had a trading volume of 489,892 shares, compared to its average volume of 1,456,086. The company has a 50-day simple moving average of $500.33 and a 200 day simple moving average of $459.58. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $544.38. The company has a market capitalization of $191.76 billion, a PE ratio of 86.31, a PEG ratio of 5.19 and a beta of 1.39.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.
Insider Activity at Intuitive Surgical
In related news, SVP Henry L. Charlton sold 40,243 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 93.06 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the firm's stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 91,178 shares of company stock valued at $45,897,071. Corporate insiders own 0.80% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently commented on ISRG. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a report on Friday, October 11th. BTIG Research set a $535.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Tuesday. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. Finally, Stifel Nicolaus lifted their price target on Intuitive Surgical from $475.00 to $525.00 and gave the company a "buy" rating in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $524.61.
Read Our Latest Report on ISRG
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.